Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-11-07
2006-11-07
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S005000
Reexamination Certificate
active
07132237
ABSTRACT:
The invention provides methods and materials involved in displaying polypeptide sequences using viruses such as avian leukosis viruses. Specifically, the invention provides nucleic acid molecules, collections of nucleic acid molecules, polypeptides, collections of polypeptides, viruses, and collections of viruses as well as methods for making nucleic acid molecules, collections of nucleic acid molecules, polypeptides, collections of polypeptides, viruses, and collections of viruses. The invention also provides methods for obtaining displayed polypeptide sequences that interact with biological molecules and/or cells as well as methods for identifying biological molecules that interact with displayed polypeptides.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 5723287 (1998-03-01), Russell et al.
patent: 6096534 (2000-08-01), Barsov et al.
Chebloune et al., “Immune Response and Resistance to Rous Sarcoma Virus Challenge of Chickens Immunized with Cell-Associated Glycoproteins Provided with a Recombinant Avian Leukosis Virus,” Journal of Virology, vol. 65, No. 10, Oct. 1991, p. 5374-5380.
Khare et al. “Replication Competent Avian Leukosis Virus: A Novel System for Stable Polypeptides Display,” Gene Therapy, Abstracts for Harold W. Siebens Conference, Oct. 5-7, 2001, vol. 8, Supplement 1, Mayo Foundation, Rochester, Minnesota, p. s9.
Khare et al., “Stable Display of Polypeptides on Avian Leukosis Virus Envelope Glycoproteins,” Abstracts of papers presented at the 2001 meeting on Vector Targeting Strategies for Gene Therapy, Mar. 15-18, 2001, Cold Spring Harbor Laboratory, NY, p. 12.
Arap et al., “Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model,”Science, 1998, 279:377-380.
Boerger et al., “Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types,”Proc. Natl. Acad. Sci. USA, 1999, 96:9867-9872.
Ellerby et al., “Anti-cancer activity of targeted pro-apoptotic peptides,”Nature Medicine, 1999, 5(9):1032-1038.
Federspiel and Hughes, “Retroviral Gene Delivery,”Methods in Cell Biology, 1998, vol. 52, Chapter 9, Academic Press, pp. 179-214.
Ferber, “Gene Therapy: Safer and Virus Free?”Science, 2001, 294(5547:1638-1642.
Holmen and Federspiel, “Selection of a Subgroup A Avian Leukosis Virus [ALV(A)] Envelope Resistant to Soluble ALV(A) Surface Glycoprotein,”Virology, 2000, 273:364-373.
Holmen et al., “Identification of Key Residues in Subgroup A Avian Leukosis Virus Envelope Determining Receptor Binding Affinity and Infectivity of Cells Expressing Chicken or Quail Tva Receptor,”J. Virol., 2001, 75(2):726-737.
Khare et al., “Stable Display of Polypeptides on Avian Leukosis Virus Envelop Glycoproteins,”Abstracts of papers presented at the 2001 meeting on Vector Targeting Strategies for Gene Therapy, Mar. 15-18, 2001, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, p. 12.
Khare et al., “Replication Competent Avian Leukosis Virus: A Novel System for Stable Polypeptides Display,”Gene Therapy, Abstracts for Harold W. Siebens Conference, Oct. 5-7, 2001, vol. 8, Supplement 1, Mayo Foundation, Rochester, Minnesota, p. S9.
Li, “Applications of display technology in protein analysis,”Nature Biotechnology, 2000, 18(12):1251-1256.
Pasqualini and Ruoslahti, “Organ targetingin vivousing phage display peptide libraries,”Nature, 1996, 380:364-366.
Pinto et al., “Restricting Expression Prolongs Expression of Foreign Genes Introduced into Animals by Retroviruses,”J. Virol., 2000, 74(21):10202-10206.
Rajotte et al., “Molecular Heterogeneity of the Vascular Endothelium Revealed by In Vivo Phage Display,”J. Clin. Invest., 1998, 102:430-437.
Rajotte and Ruoslahti, “Membrane Dipeptidase Is the Receptor for a Lung-targeting Peptide Identified byin VivoPhage Display,”J. Biol. Chem., 1999, 274(17):11593-11598.
Smith and Petrenko, “Phage Display,”Chem. Rev., 1997, 97:391-410.
Snitkovsky et al., “A TVA-Single-Chain Antibody Fusion Protein Mediates Specific Targeting of a Subgroup A Avian Leukosis Virus Vector to Cells Expressing a Tumor-Specific Form of Epidermal Growth Factor Receptor,”J. Virol., 2000, 74(20):9540-9545.
Trepel et al., “Molecular Adaptors for Vascular-Targeted Adenoviral Gene Delivery,”Human Gene Therapy, 2000, 11:1971-1981.
Valsesia-Wittmann et al., “Modifications in the Binding Domain of Avian Retrovirus Envelope Protein To Redirect the Host Range of Retroviral Vectors,”J. Virol., 1994, 68(7):4609-4619.
Federspiel Mark J.
Khare Pranay D.
Russell Stephen J.
Campell Bruce R.
Mayo Foundation for Medical Education and Research
Salvoza M. Franco
LandOfFree
Avian leukosis viruses and polypeptide display does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Avian leukosis viruses and polypeptide display, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Avian leukosis viruses and polypeptide display will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3640159